profit from every $100 of sales.
$0$100
Translational Development Acquisition
$10.88+0.05% today
+4.1% in 1 year
1-year low $10.411-year high $10.91
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $33.02 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Translational Development Acquisition sold, what it kept, and what it did with the cash.
Sales went from $0 in 2023 to $0 in 2025, with $6.36 million of profit last year.
SalesProfit
Translational Development Acquisition vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Translational Development Acquisition | 33.0× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Unusual Machines | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Armada Acquisition Corp. II | 348.4× · No profit yet |
AI analysis
An AI analyst reads Translational Development Acquisition's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| 0 | 0 | 0 | |
| – | – | – | |
| -0 | -0 | -1 | |
| -0 | -0 | -1 | |
| -0 | -0 | 6 | |
| -0.11 | -0.02 | 0.29 | |
| – | – | – | |
| – | – | – | |
| – | – | – |
Balance sheet
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 0 | 175 | 182 |
| Cash | 0 | 0 | 0 |
| Total debt | 0 | – | 0 |
| Total liabilities | 1 | 6 | 7 |
| -1 | 169 | 175 | |
| 19 | 19 | 22 | |
| – | -0.1% | -0.4% | |
| 95.6% | -0.0% | 3.6% |
Cash flow
| In millions of USD | 2023 | 2024 | 2025 |
|---|---|---|---|
| -0 | -1 | -1 | |
| – | – | – | |
| -0 | -1 | -1 | |
| Dividends paid | – | – | – |
| – | – | – | |
| – | – | – |
Valuation
- 33.0×
- –
- –
- 1.0×
- –
- –
- –
- -0.3%
- 3.0%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.5%
- 69.2%
- 3.6%
- 3.4%
- -0.5%
- –
Growth
- –
- –
- +28.5%
- –
- +62.1%
Financial health
- -0.5×
- 0.00
- 0.3%
- –
- 0.09
- 0.09
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 10%of 749
Bottom 8%of 604
Bottom 17%of 872
Bottom 23%of 931
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | 0.06 | – | – |
| Mar 16, 2026 | 0.07 | – | – |
| Sep 30, 2021 | 0.93 | – | – |
| Aug 16, 2021 | -0.23 | – | – |
| Mar 30, 2021 | 0.02 | – | – |
| Mar 15, 2021 | -0.03 | – | – |
| Sep 30, 2020 | -0.05 | – | – |
| Jun 30, 2020 | -0.04 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
43No pass
Philip Fisher
39No pass
Peter Lynch
62Pass
Joel Greenblatt
9No pass
Charlie Munger
37No pass
Terry Smith
31No pass
Questions about Translational Development Acquisition
Is Translational Development Acquisition a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Translational Development Acquisition AI analysis
What does Translational Development Acquisition do?
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It is in Shell Companies.
Does Translational Development Acquisition pay a dividend?
No. Translational Development Acquisition does not pay a dividend at the moment.
Is Translational Development Acquisition stock halal?
Questionable. Translational Development Acquisition sits in a grey zone: scholars disagree about its industry. How we check
How has Translational Development Acquisition stock done over the past year?
Up 4.1% over the past twelve months, to $10.88. It traded between $10.41 and $10.91, close to its high.
Who are Translational Development Acquisition's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Unusual Machines, Drugs Made In America Acquisition II and Armada Acquisition Corp. II. The peers table on this page compares their profit, growth and price with Translational Development Acquisition's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.